Navigation Links
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Date:11/24/2008

About ALO-01 (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules

ALO-01(morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules (EMBEDA(TM)), Alpharma's product candidate currently under review with the FDA, was developed with Alpharma's proprietary technology, which combines an extended-release opioid with sequestered naltrexone, an opioid antagonist. In clinical trials, when ALO-01 Capsules were taken as directed, pain relief was provided and the sequestered naltrexone passed through the body without observed clinical effect. If an ALO-01 Capsule is crushed or dissolved in alcohol, which are common approaches abusers use to tamper with an opioid product in order to gain euphoria; both the morphine and the naltrexone are released. When both are released, study results showed that the euphoric effect of morphine was significantly reduced. EMBEDA(TM) is a proposed brand name that is subject to FDA approval.

About Special Items

Under Generally Accepted Accounting Principles ("GAAP"), reported "net earnings" and "diluted earnings per share" include special items. In addition to the reported results determined in accordance with GAAP, King provides its net earnings and diluted earnings per share results excluding special items. These non-GAAP financial measures exclude special items which are those particular material income or expense items that King considers to be unrelated to the Company's ongoing, underlying business, non-recurring, or not generally predictable. Such items include, but are not limited to, merger and restructuring expenses; non-capitalized expenses associated with acquisitions, such as in-process research and development charges and inventory valuation adjustment charges; charges resulting from the early extinguishment of debt; asset impairment charges; expenses of drug recalls; and gains and losses resultin
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
6. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
7. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
8. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
9. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
10. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
11. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... New York, New York (PRWEB) September 02, 2014 ... metal-on-metal version of the DePuy Pinnacle hip implant ... jury selection begins today in the U.S. District ... reports. According to court documents, Johnson & Johnson ... 6,000 lawsuits that allege the all-metal hip caused ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Alliance Strategies ... and multi-channel email marketing is pleased to announce it ... Firearms & Freedom as well as ... represent more than one million concerned Americans who can ... , “We are honored to continue providing our ...
(Date:9/2/2014)... novel polypill increases patient adherence to treatment following ... to new study results reported at the European ... Spain. According to Principal Investigator Valentin Fuster, MD, ... School of Medicine at Mount Sinai and General ... Carlos III (CNIC) in Madrid, Spain, the novel ...
(Date:9/2/2014)... the University of California, San Diego School of Medicine ... breast cancer. The findings, reported in the current ... of breast cancer mortality worldwide. An estimated 40,000 women ... according to the American Cancer Society. , "The take-home ... a way to target breast cancer metastasis through a ...
(Date:9/2/2014)... many health risks, including heart disease and diabetes, but ... to mitigate one often-overlooked risk: not buckling up in ... H. Jacobson, a professor of computer science and of ... with a decrease in seatbelt usage. However, these effects ... , "Primary seatbelt laws lead to increased use of ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 4Health News:ASG Continues to Bring New Lists to Market 2Health News:ASG Continues to Bring New Lists to Market 3Health News:New polypill increases heart attack patients' medication adherence 2Health News:New polypill increases heart attack patients' medication adherence 3Health News:Enzyme controlling metastasis of breast cancer identified 2Health News:Seatbelt laws encourage obese drivers to buckle up 2
... ... Distinguished Professor of Critical Care Medicine at Children’s National Medical Center , ... Washington, DC (Vocus) March 24, ... L. Wessel, MD , as the first IKARIA® Distinguished Professor of Critical Care Medicine. ...
... cases are few after time, but death risk is ... (HealthDay News) -- Breast cancer recurrence in the same ... predictor of subsequent cancer spread and death in patients ... study has found. , Researchers analyzed data from 7,749 ...
... ... ... April of 2009, Director/Producer James Takata, Writers/Producers Zach Lewis and Jim Mahoney, and Producer ... a short film about Stephen, a talented young composer and pianist who discovers he ...
... This release is available in Spanish . ... that some breast cancer patients taking tamoxifen may not ... they have also been taking selective serotonin reuptake inhibitors ... important enzyme. Now researchers have developed a strategy for ...
... Despite the aches and pains that occur in old age, ... experiences from their past. A new study, reported in ... http://www.elsevier.com/locate/cortex ), reveals that older adults, ability to remember the ... in which the brain processes emotional content. In the ...
... ... Below is recent testimonial on how well the product works. This Herbal Tea can be ... ... Snoring. Below is recent testimonial on how well the product works. This Herbal Tea can ...
Cached Medicine News:Health News:$2.5 Million Gift Aims to Help Children Survive and Thrive 2Health News:$2.5 Million Gift Aims to Help Children Survive and Thrive 3Health News:Breast Cancer's Return in Original Tumor Site a Bad Sign 2Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 2Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 3Health News:Doctors must collaborate so that patients get full benefit of tamoxifen treatment 2Health News:Doctors must collaborate so that patients get full benefit of tamoxifen treatment 3Health News:Older adults remember the good times 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 3
(Date:9/2/2014)... Sept. 2, 2014 ResMed (NYSE: RMD ... devices in the United States . ... lightweight, and user-friendly life support ventilators. ... and ease of use for patients suffering from neuromuscular ... and childhood respiratory disorders. The U.S. launch comes on ...
(Date:9/2/2014)... , Sept. 2, 2014   Mast Therapeutics, Inc . (NYSE ... Brian M. Culley , will present at the Rodman and Renshaw ... 2014 at 2:55 p.m. Eastern time in the Holmes II Salon ... . Interested parties can access a live ... at www.masttherapeutics.com . An archived presentation will be available on ...
(Date:9/2/2014)... , Sept. 2, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... collagenase-based products marketed as XIAFLEX ® in the U.S. ... BioSpecifics, President, Tom Wegman , will present at the ... Rodman & Renshaw 16 th ... ) Tuesday, September 9, 2014 at 9:10 a.m. EDT ...
Breaking Medicine Technology:ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 2Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 3BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2
More Info Lacrimal Intubation Set. Size: Probes 23g x 7"....
... Robot Stainer HMS 760 X is equipped ... and transferred during program execution. This feature ... system contributes to a significant reduction of ... glass cover and a vapor escape via ...
... Designed for applications in the field of ... also be used as a back-up instrument in ... size and safety clamps for the cover, the ... Boasting an optional 12-volt transformer, it can be ...
... The OTF5000 represents the new style ... long-established and reliable OTF/AS cryostat, the ... systems in the ever-reliable and powerful ... options plus money-saving package deals makes ...
Medicine Products: